CDKN3 as a key regulator of G2M phase in triple‐negative breast cancer: Insights from multi‐transcriptomic analysis
Sign Up to like & getrecommendations! Published in 2025 at "IUBMB Life"
DOI: 10.1002/iub.2922
Abstract: Triple‐negative breast cancer (TNBC) remains a significant global health challenge, emphasizing the need for precise identification of patients with specific therapeutic targets and those at high risk of metastasis. This study aimed to identify novel… read more here.
Keywords: cdkn3; cancer; cell cycle; analysis ... See more keywords